In medio stat virtus:不对称的萨尔金属复合物,具有改善的生物特性
Luisa D'Anna1, Aurane Froux1,2, Riccardo Bonsignore1
1University of Palermo, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies; Viale delle Scienze, Edificio 17, 90128 Palermo, Italy. alessio.terenzi@unipa.it.
Dalton transactions (Cambridge, England : 2003)
|February 23, 2026
概括
不对称的盐复合物显示出作为抗癌剂的前景. 单离子复合体通过诱导亡,表现出改善的溶解性,细胞吸收和对胰腺癌细胞的强有力的细胞毒性.
科学领域:
- 协调化学 协调化学
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 金属复合物,特别是那些基于Salphen配体的复合物,正在被探索它们的治疗潜力.
- 了解结构-活性关系对于开发有效的抗癌药物至关重要.
研究的目的:
- 合成和表征新型Zn(II) 盐复合物,具有不同的联体修饰.
- 为了评估它们的DNA结合,细胞吸收和抗癌功效.
- 研究不对称性在调节生物性质中的作用.
主要方法:
- 对称和不对称Zn (II) 盐复合物的合成,包括不对称衍生物的机械化学.
- 评估DNA结合亲和力,特别是G-四重复 (G4) DNA.
- 对细胞吸收机制和对癌症细胞系的细胞毒性进行评估.
- 亡诱导试验,包括PARP裂变分析.
主要成果:
- 一个对称的中性复合体显示了细胞毒性,但溶解性差,G4 DNA 结合.
- 一个对称的二元复合物稳定了高度的G4DNA,但缺乏细胞活性.
- 这种不对称的单离子复合体表现出增强的水溶性,通过被动运输有效的细胞吸收,以及对胰腺癌细胞显著的细胞毒性.
- 非对称复合物诱导了亡,由PARP裂变证明.
结论:
- 不对称的萨尔芬复合体为抗癌药物开发提供了有利的特性平衡.
- 单离子复合体通过抑制癌细胞活力和诱导亡,显示出作为治疗剂的显著潜力.
- 这些发现为合理设计基于萨尔芬的金属疗法提供了基础.
相关概念视频
Complexation Equilibria: The Chelate Effect
1.4K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.4K
Complexation Equilibria: Factors Influencing Stability of Complexes
879
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
879
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.9K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.9K
Metal-Ligand Bonds
24.7K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.7K
Extraction: Advanced Methods
1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
EDTA: Chemistry and Properties
3.6K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
3.6K


